This authorization is the first authorized treatment of a patient with MDMA outside of a clinical trial in Canadian historyVANCOUVER, British Columbia,...
As we move into the 2nd quarter of 2023, we take a look at Q1 and other trends in the psychedelic medicine sector The post Q1...
The article Which Psychedelic Medicine Companies Have the Best Financials? was originally published on Microdose. As I have written many times before,...
The first three months of 2023 have been a whirlwind for the psychedelic industry– to say the least. Though it has been a particularly difficult quarter,...
The compounds have shown positive results in pre-clinical studies. The post Mindset Pharma Files Patents for Nonhallucinogenic Psychedelic Drugs to Treat...
TORONTO, April 26, 2023 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”), a drug discovery...
TORONTO, March 28, 2023 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”) today issued...
Eight patients sued the government at the end of July last year over what they believe is a violation of constitutional rights The post Psilocybin access...
The article News You Might Have Missed: March 20th, 2023 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
The article Reunion Sues Mindset Pharma & Field Trip Looks at Closing Clinics was originally published on Microdose. Reunion Neuroscience Files Lawsuit...